[EN] SUBSTITUTED OXADIAZOLES FOR COMBATING PHYTOPATHOGENIC FUNGI [FR] OXADIAZOLES SUBSTITUÉS UTILISÉS POUR LUTTER CONTRE DES CHAMPIGNONS PHYTOPATHOGÈNES
[EN] SUBSTITUTED OXADIAZOLES FOR COMBATING PHYTOPATHOGENIC FUNGI [FR] OXADIAZOLES SUBSTITUÉS UTILISÉS POUR LUTTER CONTRE DES CHAMPIGNONS PHYTOPATHOGÈNES
[EN] NOVEL TRIFLUOROMETHYL-OXADIAZOLE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE<br/>[FR] NOUVEAUX DÉRIVÉS DE TRIFLUOROMÉTHYL-OXADIAZOLE ET LEUR UTILISATION POUR LE TRAITEMENT DE MALADIES
申请人:NOVARTIS AG
公开号:WO2013008162A1
公开(公告)日:2013-01-17
The invention relates to novel trifluoromethyl-oxadiazole derivatives of formula (I), and pharmaceutically acceptable salts thereof, (I) in which all of the variables are as defined in the specification, pharmaceutical compositions thereof, pharmaceutical combinations thereof, and their use as medicaments, particularly for the treatment of neurodegeneration, muscle atrophy or metabolic syndrome via inhibition of HDAC4.
NOVEL TRIFLUOROMETHYL-OXADIAZOLE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE
申请人:Hebach Christina
公开号:US20140142105A1
公开(公告)日:2014-05-22
The invention relates to novel trifluoromethyl-oxadiazole derivatives of formula (I), and pharmaceutically acceptable salts thereof, (I) in which all of the variables are as defined in the specification, pharmaceutical compositions thereof, pharmaceutical combinations thereof, and their use as medicaments, particularly for the treatment of neurodegeneration, muscle atrophy or metabolic syndrome via inhibition of HDAC4.
Trifluoromethyl-oxadiazole derivatives and their use in the treatment of disease
申请人:Hebach Christina
公开号:US09056843B2
公开(公告)日:2015-06-16
The invention relates to novel trifluoromethyl-oxadiazole derivatives of formula (I), and pharmaceutically acceptable salts thereof, (I) in which all of the variables are as defined in the specification, pharmaceutical compositions thereof, pharmaceutical combinations thereof, and their use as medicaments, particularly for the treatment of neurodegeneration, muscle atrophy or metabolic syndrome via inhibition of HDAC4.
Substituted oxadiazoles for combating phytopathogenic fungi
申请人:BASF SE
公开号:US10785980B2
公开(公告)日:2020-09-29
The present invention relates to novel trifluoromethyl oxadiazoles of the formula I, or an N-oxide, and/or their agriculturally useful salts; to their use for controlling phytopathogenic fungi; to a method for combating phytopathogenic harmful fungi, which process comprises treating the fungi or the plants, the soil or seeds to be protected against fungal attack, with an effective amount of at least one compound of the formula I, or an N-oxide, or an agriculturally acceptable salt thereof; to agrochemical compositions comprising at least one such compound; and to agrochemical compositions further comprising seeds.
本发明涉及式 I 的新型三氟甲基噁二唑或其 N-氧化物和/或其农业上有用的盐;涉及它们在控制植物病原真菌方面的用途;涉及一种防治植物病原性有害真菌的方法,该方法包括用有效量的至少一种式 I 的化合物或其 N-氧化物或其农业上可接受的盐处理真菌或植物、土壤或种子,以防止真菌侵袭;涉及包含至少一种此类化合物的农用化学品组合物;以及涉及进一步包含种子的农用化学品组合物。
SUBSTITUTED OXADIAZOLES FOR COMBATING PHYTOPATHOGENIC FUNGI